By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biologics, Inc. 

120 Weston Oaks Court

Cary  North Carolina  27513  United States
Phone: 800-856-1984 Fax: 919-256-0794



Company News
COTELLIC (Cobimetinib) Approved In Combination For BRAF V600+ Metastatic Melanoma, Available Immediately Biologics, Inc. (NC) 11/17/2015 12:36:57 PM
Tagrisso (Osimertinib) Approved For Advanced Lung Cancer, Available Immediately At Biologics, Inc. (NC) 11/17/2015 10:16:08 AM
LONSURF (Trifluridine And Tipiracil) Approved For Refractory Metastatic Colorectal Cancer, Available At Biologics, Inc. (NC) 10/7/2015 10:14:42 AM
Biologics, Inc. (NC) Selected To Dispense AstraZeneca PLC (AZN)’s IRESSA (Gefitinib) 8/13/2015 10:20:18 AM
Biologics, Inc. (NC) to Hire 350, Moves Into New N.C. Headquarters 7/7/2015 10:12:37 AM
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 4/15/2015 8:25:55 AM
Bayer HealthCare Pharmaceuticals (BAYA.F) Has Selected Biologics, Inc. (NC) As A Limited Distribution Network Provider For NEXAVAR (Sorafenib) And STIVARGA (Regorafenib) 2/23/2015 12:49:05 PM
Ibrance® (Palbociclib) Approved For ER+, HER2- Advanced Breast Cancer, Available Immediately At Biologics, Inc. (NC) 2/6/2015 10:46:53 AM
Biologics, Inc. (NC) Is Pleased To Announce The Continued Clinical Support Of Oncology Therapies For Silverscript Prescription Drug Plan 1/20/2015 8:30:43 AM
LYNPARZA™ (Olaparib) Approved For The Treatment Of Advanced Relapsed Ovarian Cancer In Patients With Germline BRCA Mutations, Available Exclusively At Biologics, Inc. (NC) 12/22/2014 11:24:01 AM